221 related articles for article (PubMed ID: 24344719)
1. P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects.
Wang H; Sun R; Lin H; Hu WH
Cancer Sci; 2013 Dec; 104(12):1553-9. PubMed ID: 24344719
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
6. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
[TBL] [Abstract][Full Text] [Related]
8. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
9. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
10. Double positivity for HPV-DNA/p16
Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
14. Utility of the Roche Cobas 4800 for detection of high-risk human papillomavirus in formalin-fixed paraffin-embedded oropharyngeal squamous cell carcinoma.
Pettus JR; Wilson TL; Steinmetz HB; Lefferts JA; Tafe LJ
Exp Mol Pathol; 2017 Feb; 102(1):47-49. PubMed ID: 27939577
[TBL] [Abstract][Full Text] [Related]
15. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
[TBL] [Abstract][Full Text] [Related]
16. Current Perspective on HPV-Associated Oropharyngeal Carcinomas and the Role of p16 as a Surrogate Marker of High-Risk HPV.
Gurín D; Slávik M; Shatokhina T; Kazda T; Šána J; Slabý O; Hermanová M
Klin Onkol; 2019; 32(4):252-260. PubMed ID: 31426640
[TBL] [Abstract][Full Text] [Related]
17. Utility of p16 and HPV testing in oropharyngeal squamous cell carcinoma: An institutional review.
Abdelhakam DA; Huenerberg KA; Nassar A
Diagn Cytopathol; 2021 Jan; 49(1):54-59. PubMed ID: 32845095
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.
Ou P; Gear K; Rahnama F; Thomas S; Nagappan R; Kee D; Waldvogel-Thurlow S; Jain R; McIvor N; Izzard M; Douglas R
ANZ J Surg; 2018 Apr; 88(4):E278-E283. PubMed ID: 27647686
[TBL] [Abstract][Full Text] [Related]
20. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
Laco J; Vosmikova H; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Nekvindova J; Vosmik M; Cermakova E; Ryska A
Virchows Arch; 2011 Feb; 458(2):179-87. PubMed ID: 21221634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
